Novo Nordisk files 14 new lawsuits against unapproved semaglutide drugs
These filings come after FDA issued its latest warning to patients and healthcare professionals about the serious dangers of compounded GLP-1 drugs
These filings come after FDA issued its latest warning to patients and healthcare professionals about the serious dangers of compounded GLP-1 drugs
The inspection was conducted from July 22-25, 2025
The scheme aims to avoid disruption in supply of critical active pharmaceutical ingredients (APIs) used to make critical drugs
The company received one observation in the Form-483
During Q1FY26, the company incurred Capex of ~Rs. 48.5 crores mainly towards capacity expansion, backward integration and finished formulation R&D
Phosphate-based excipients provide higher bulk densities and enable the reduction of the tablet sizes
This achievement underscores our unwavering commitment to upholding the highest standards of quality, safety, and regulatory compliance
Azelis will strengthen its presence in the domestic market by leveraging portfolio synergies, actively consolidating the business, and creating value for all stakeholders
The companies admitted taking part in the cartel in exchange for reduced fines but Alchem did not settle
Subscribe To Our Newsletter & Stay Updated